TCG Crossover GP I, LLC 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:15 pm Sale | 2026-06-30 | 13G | ENTRADA THERAPEUTICS INC TRDA | TCG Crossover GP I, LLC | 1,060,230 2.700% | -857,114 (-44.70%) | Filing |
| 2025-11-25 4:29 pm Purchase | 2025-11-19 | 13G | ENTRADA THERAPEUTICS INC TRDA | TCG Crossover GP I, LLC | 1,917,344 5.000% | 1,917,344 (New Position) | Filing |